Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

AHR as novel therapeutic target for polycystic ovary syndrome

March 29, 2021

RZ-358 shows promise for treating PGBH

March 26, 2021

Japanese approval of Isturisa for endogenous Cushing's syndrome

March 26, 2021

Data on weekly basal insulin LY-3209590 in patients with T2D presented

March 26, 2021

Synlogic achieves proof of mechanism for SYNB-8802 in dietary hyperoxaluria study

March 25, 2021

Ostabaro approved in Japan for osteoporosis in patients at high risk of fractures

March 24, 2021

LIBERTY randomized withdrawal study of relugolix combination therapy meets primary endpoint

March 24, 2021

LINC-4 phase III data presented for osilodrostat in patients with Cushing's disease

March 24, 2021

Izcargo approved in Japan for the treatment of MPS II

March 24, 2021

FDA approves Zegalogue to treat severe hypoglycemia in children and adults with diabetes

March 23, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...